Niacin And Niacinamide Market - Forecast(2024 - 2030)
Niacin and Niacinamide Market Overview
The rising healthcare spending, customer preference for healthier eating
habits, rising demand from cosmeceutical and pharmaceutical industry owing to
its ability to protect skin cells from UV rays and benefiting against a
variety of diseases are all driving the global Niacin and niacinamide market. Additionally,
increasing prevalence of chronic diseases and rising government initiatives to
raise awareness about the benefits of niacin and niacinamide are also likely to
provide growth opportunities for the niacin and niacinamide industry. However,
the stringent regulations along with, prominent side effects associated with
niacin and niacinamide is predicted to pose a major threat to the market's
growth during the forecast period 2021-2026.
Report Coverage
Key Takeaways
- Geographically, The Europe region held 39.6% of the total market share in 2020 owing to the rising cases of downer cow syndrome (DCS) in dairy cattle, as well as an increase in cases of childhood obesity.
- Rising demand from cosmeceutical and pharmaceutical industry owing to its ability of protecting skin cells from UV rays and benefiting against a variety of diseases are the major driving force for Niacin and Niacinamide Market during the forecast period 2021-2026.
- Detailed analysis on the Strength, Weakness and Opportunities of the prominent players operating in the market will be provided in the Niacin and Niacinamide Market.
Niacin and Niacinamide Market - By Geography, 2020.
Niacin and Niacinamide Market Segment Analysis - By Form
On the
basis of form, the market is divided into Powder, Granular and Liquid form. Powder
segment account for the highest market share in 2020 owing to
its higher shelf life and low cost when compared with liquid form. Additionally
the onset of action of powdered Niacin and Niacinamide is rapid as compared to
other forms thereby driving the market growth of the segment.
However the
liquid segment accounted for the fastest market share in 2020 and it is
expected to expand rapidly at a significant CAGR of 7.6% during the forecast
period 2021-2026 owing to faster absorption rates and easy flexibility with
dosing.
Niacin and Niacinamide Market Segment Analysis - By Application
Based
on End User, the global Niacin and Niacinamide Market
is segmented into Pharmaceutics, Cosmeceutics, Human Nutrition, Animal Nutrition and
others. In 2020, the animal nutrition segment
dominated the Niacin and Niacinamide Market. The Dominance of the segment can largely be attributed to its property
which aid in the reduction of Ketosis in dairy cattle, resulting in increased
milk production. According to recent
lactation studies Cows supplemented with niacin reliably produce more milk with
higher fat percentages.
However cosmeceuticals
application segment accounted for the fastest market share in 2020 and is projected
to grow at a CAGR of 7.9% during the forecast period 2021-2026. The dominance
is due to increasingly usage of Niacinamide in the skin care product owing to
its ability to protect skin cells from UV rays.
Niacin and Niacinamide Market Segment Analysis - By Geography
Based on
geography, Europe dominated the Niacin and Niacinamide Market with a region
share of 39.6% in 2020 followed by North America and APAC. Rising cases of downer cow syndrome (DCS) in
dairy cattle, as well as increasing cases of childhood obesity, are the major factors
propelling the growth of Niacin and Niacinamide Market in this region. Moreover,
the presence of large number of pharmaceutical and cosmeceutical companies that
invest heavily on the research along is predicted to drive the market growth in
this region.
Asia Pacific region is predicted to see the demand maturing in Niacin and Niacinamide Market owing to the rapid advancement in chemical studies, as well as the increasing healthcare expenditure in emerging economies such as China and India, which is predicted to create new opportunities for the regional Niacin and Niacinamide industry.
Niacin and Niacinamide Market Drivers
Application in Disease Prevention
Niacin and niacinamide have been shown to be beneficial
in the treatment of a variety of diseases, including Pellagra and Melanoma.
Taking extreme disorders like Schizophrenia into account, these chemicals have
shown to be effective, and researchers are emphasizing the intake of niacin and
niacinamide to combat Schizophrenia. Additionally, in vitro studies have shown
that niacinamide has the ability to suppress melanoma cell proliferation and
speed up apoptosis which is further set to propel the market forward during the
forecast period 2021-2026.
Niacin and Niacinamide Market Challenge
Adverse Side Effects Associated with Consumption of Niacin
After years of
being the go-to prescription for cholesterol treatment, niacin is no longer
being recommended to patients because it has been linked to an increased risk
of mortality and negative side effects. Niacin is losing its reputation for
lowering the risk of strokes and heart attacks. There was no improvement in the
risk of stroke and heart attacks in elderly people with cardiovascular
disorders in the age group 50-80 who took extended release niacin and
laropiprant. Concerns about niacin supplementation's dangerous side effects,
such as liver complications, excessive bleeding, infections, and gout, are also
being investigated all these factor are predicted to act as a major impediment to
the Niacin and Niacinamide Market's growth during the forecast period 2021-2026.
Niacin and Niacinamide Market Landscape:
Product
launches, mergers and acquisitions, joint ventures, and geographical expansions
are key strategies adopted by players in the Niacin and Niacinamide Market. Key
companies of this market are Brother Enterprises Holding Co., Ltd., Zhejiang
NHU Company Ltd., Fagron NV, Vertellus Specialties Inc., Jubilant Life Sciences
Limited, Evonik Industries AG, Foodchem International Corporation, BASF SE,
Merck KGaA, Bactolac Pharmaceutical Inc., Koninklijke DSM N.V., and Lonza Group
AG.
Developments:
- In April 2020, ScieGen, a subsidiary of Bactolac Pharmaceutical, bolster its production to meet growing demandsof nutraceutical industry.
- In July 2019, Jubilant Life Sciences announces price increase of 10% for Vitamin B3 (Niacin and Niacinamide).
Relevant reports
For more Lifesciences and Healthcare Market related reports, please click here
LIST OF TABLES
LIST OF FIGURES
1.US Niacin And Niacinamide Market Revenue, 2023-2030 ($M)2.Canada Niacin And Niacinamide Market Revenue, 2023-2030 ($M)
3.Mexico Niacin And Niacinamide Market Revenue, 2023-2030 ($M)
4.Brazil Niacin And Niacinamide Market Revenue, 2023-2030 ($M)
5.Argentina Niacin And Niacinamide Market Revenue, 2023-2030 ($M)
6.Peru Niacin And Niacinamide Market Revenue, 2023-2030 ($M)
7.Colombia Niacin And Niacinamide Market Revenue, 2023-2030 ($M)
8.Chile Niacin And Niacinamide Market Revenue, 2023-2030 ($M)
9.Rest of South America Niacin And Niacinamide Market Revenue, 2023-2030 ($M)
10.UK Niacin And Niacinamide Market Revenue, 2023-2030 ($M)
11.Germany Niacin And Niacinamide Market Revenue, 2023-2030 ($M)
12.France Niacin And Niacinamide Market Revenue, 2023-2030 ($M)
13.Italy Niacin And Niacinamide Market Revenue, 2023-2030 ($M)
14.Spain Niacin And Niacinamide Market Revenue, 2023-2030 ($M)
15.Rest of Europe Niacin And Niacinamide Market Revenue, 2023-2030 ($M)
16.China Niacin And Niacinamide Market Revenue, 2023-2030 ($M)
17.India Niacin And Niacinamide Market Revenue, 2023-2030 ($M)
18.Japan Niacin And Niacinamide Market Revenue, 2023-2030 ($M)
19.South Korea Niacin And Niacinamide Market Revenue, 2023-2030 ($M)
20.South Africa Niacin And Niacinamide Market Revenue, 2023-2030 ($M)
21.North America Niacin And Niacinamide By Application
22.South America Niacin And Niacinamide By Application
23.Europe Niacin And Niacinamide By Application
24.APAC Niacin And Niacinamide By Application
25.MENA Niacin And Niacinamide By Application
26.Niacin and Niacinamide Market Competitive Landscape, Sales /Revenue, 2015-2018 ($Mn/$Bn)